vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and WESTAMERICA BANCORPORATION (WABC). Click either name above to swap in a different company.

WESTAMERICA BANCORPORATION is the larger business by last-quarter revenue ($63.3M vs $38.9M, roughly 1.6× CODEXIS, INC.). WESTAMERICA BANCORPORATION runs the higher net margin — 43.9% vs 24.7%, a 19.3% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs -9.0%). WESTAMERICA BANCORPORATION produced more free cash flow last quarter ($119.7M vs $19.6M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs -8.6%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Westamerica Bancorporation is a regional bank holding company headquartered in California, U.S. It operates via its wholly owned banking subsidiary to provide full-spectrum retail and commercial banking services, including deposit products, business and consumer loans, wealth management, and payment services, primarily serving individual consumers, SMEs and local institutional clients in northern and central California.

CDXS vs WABC — Head-to-Head

Bigger by revenue
WABC
WABC
1.6× larger
WABC
$63.3M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+90.3% gap
CDXS
81.3%
-9.0%
WABC
Higher net margin
WABC
WABC
19.3% more per $
WABC
43.9%
24.7%
CDXS
More free cash flow
WABC
WABC
$100.1M more FCF
WABC
$119.7M
$19.6M
CDXS
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
-8.6%
WABC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
WABC
WABC
Revenue
$38.9M
$63.3M
Net Profit
$9.6M
$27.8M
Gross Margin
94.8%
Operating Margin
27.1%
59.8%
Net Margin
24.7%
43.9%
Revenue YoY
81.3%
-9.0%
Net Profit YoY
192.5%
-12.3%
EPS (diluted)
$0.13
$1.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
WABC
WABC
Q4 25
$38.9M
$63.3M
Q3 25
$8.6M
$63.7M
Q2 25
$15.3M
$64.6M
Q1 25
$7.5M
$66.4M
Q4 24
$21.5M
$69.6M
Q3 24
$12.8M
$74.1M
Q2 24
$8.0M
$74.3M
Q1 24
$17.1M
$75.8M
Net Profit
CDXS
CDXS
WABC
WABC
Q4 25
$9.6M
$27.8M
Q3 25
$-19.6M
$28.3M
Q2 25
$-13.3M
$29.1M
Q1 25
$-20.7M
$31.0M
Q4 24
$-10.4M
$31.7M
Q3 24
$-20.6M
$35.1M
Q2 24
$-22.8M
$35.5M
Q1 24
$-11.5M
$36.4M
Gross Margin
CDXS
CDXS
WABC
WABC
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
WABC
WABC
Q4 25
27.1%
59.8%
Q3 25
-220.3%
59.5%
Q2 25
-83.9%
60.5%
Q1 25
-271.6%
63.0%
Q4 24
-34.2%
62.8%
Q3 24
-129.0%
64.5%
Q2 24
-284.9%
64.8%
Q1 24
-69.6%
65.2%
Net Margin
CDXS
CDXS
WABC
WABC
Q4 25
24.7%
43.9%
Q3 25
-228.1%
44.3%
Q2 25
-86.6%
45.0%
Q1 25
-274.3%
46.7%
Q4 24
-48.4%
45.6%
Q3 24
-160.8%
47.3%
Q2 24
-285.2%
47.8%
Q1 24
-67.4%
48.0%
EPS (diluted)
CDXS
CDXS
WABC
WABC
Q4 25
$0.13
$1.12
Q3 25
$-0.22
$1.12
Q2 25
$-0.16
$1.12
Q1 25
$-0.25
$1.16
Q4 24
$-0.12
$1.19
Q3 24
$-0.29
$1.31
Q2 24
$-0.32
$1.33
Q1 24
$-0.16
$1.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
WABC
WABC
Cash + ST InvestmentsLiquidity on hand
$78.2M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$50.5M
$933.5M
Total Assets
$147.8M
$6.0B
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
WABC
WABC
Q4 25
$78.2M
Q3 25
$58.7M
Q2 25
$66.3M
Q1 25
$59.8M
Q4 24
$73.5M
Q3 24
$90.3M
Q2 24
$73.2M
Q1 24
$85.5M
Total Debt
CDXS
CDXS
WABC
WABC
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
CDXS
CDXS
WABC
WABC
Q4 25
$50.5M
$933.5M
Q3 25
$38.5M
$931.6M
Q2 25
$55.6M
$921.8M
Q1 25
$49.6M
$923.1M
Q4 24
$66.9M
$890.0M
Q3 24
$73.4M
$909.0M
Q2 24
$61.4M
$815.6M
Q1 24
$79.3M
$791.7M
Total Assets
CDXS
CDXS
WABC
WABC
Q4 25
$147.8M
$6.0B
Q3 25
$124.0M
$5.9B
Q2 25
$138.2M
$5.8B
Q1 25
$128.9M
$6.0B
Q4 24
$149.0M
$6.1B
Q3 24
$148.2M
$6.2B
Q2 24
$132.0M
$6.3B
Q1 24
$149.6M
$6.5B
Debt / Equity
CDXS
CDXS
WABC
WABC
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
WABC
WABC
Operating Cash FlowLast quarter
$20.1M
$121.9M
Free Cash FlowOCF − Capex
$19.6M
$119.7M
FCF MarginFCF / Revenue
50.3%
189.0%
Capex IntensityCapex / Revenue
1.3%
3.5%
Cash ConversionOCF / Net Profit
2.09×
4.38×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M
$213.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
WABC
WABC
Q4 25
$20.1M
$121.9M
Q3 25
$-7.7M
$29.4M
Q2 25
$-18.0M
$23.5M
Q1 25
$-13.8M
$42.4M
Q4 24
$-16.5M
$141.6M
Q3 24
$-13.0M
$40.6M
Q2 24
$-12.2M
$19.0M
Q1 24
$-7.8M
$52.2M
Free Cash Flow
CDXS
CDXS
WABC
WABC
Q4 25
$19.6M
$119.7M
Q3 25
$-7.9M
$28.7M
Q2 25
$-20.5M
$22.8M
Q1 25
$-15.1M
$42.2M
Q4 24
$-18.2M
$139.8M
Q3 24
$-14.0M
$40.1M
Q2 24
$-12.6M
$18.6M
Q1 24
$-8.9M
$52.1M
FCF Margin
CDXS
CDXS
WABC
WABC
Q4 25
50.3%
189.0%
Q3 25
-91.7%
45.1%
Q2 25
-133.6%
35.3%
Q1 25
-199.6%
63.5%
Q4 24
-85.0%
201.0%
Q3 24
-109.0%
54.1%
Q2 24
-157.5%
25.0%
Q1 24
-52.2%
68.7%
Capex Intensity
CDXS
CDXS
WABC
WABC
Q4 25
1.3%
3.5%
Q3 25
2.1%
1.1%
Q2 25
16.4%
1.1%
Q1 25
16.7%
0.3%
Q4 24
8.3%
2.5%
Q3 24
7.8%
0.7%
Q2 24
5.0%
0.6%
Q1 24
6.6%
0.2%
Cash Conversion
CDXS
CDXS
WABC
WABC
Q4 25
2.09×
4.38×
Q3 25
1.04×
Q2 25
0.81×
Q1 25
1.37×
Q4 24
4.47×
Q3 24
1.16×
Q2 24
0.54×
Q1 24
1.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons